Nucleoporin93: A silent protector in vascular health
"Research in the last several decades has established endothelial cells (ECs) as a dynamic interface critical for vascular protection”
2024-11-26
(Press-News.org)
"Research in the last several decades has established endothelial cells (ECs) as a dynamic interface critical for vascular protection.”
BUFFALO, NY- November 26, 2024 – This editorial was published by Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) in Volume 16, Issue 17, titled, “The silent protector: Nucleoporin93’s role in vascular health.”
Written by Julia Michalkiewicz, Tung D. Nguyen, and Monica Y. Lee from The University of Illinois at Chicago College of Medicine, this editorial highlights the critical role of a protein called Nucleoporin93 (Nup93) in maintaining blood vessel health as we age. The authors review new research suggesting that Nup93 could be a key target for treatments to prevent or reduce aging-related diseases, including heart disease and stroke.
Cardiovascular diseases remain the leading causes of death worldwide, with aging identified as a major risk factor. Vascular health declines as endothelial cells (EC)—the protective lining of blood vessels—lose their functionality with age. This deterioration leads to inflammation, arterial stiffening, and reduced blood flow, significantly increasing the risk of life-threatening diseases. The authors underscore the urgent need to uncover the molecular mechanisms driving these changes.
Nup93 plays an essential role within nuclear pore complexes (NPCs)—gateways that regulate molecular exchanges between the cell nucleus and cytoplasm. Age-related loss of Nup93 disrupts this delicate system, weakening endothelial cells function and accelerating vascular aging. Researchers identified Nup93 as a crucial protector of endothelial health, preventing harmful protein build-ups such as Yes-associated protein (Yap), a known driver of inflammation and cellular aging.
Excitingly, scientists have discovered that restoring Nup93 levels in damaged endothelial cells can reverse some of these harmful effects. They also found that blocking Yap can prevent issues caused by low Nup93 levels. These findings highlight the potential for new medicines or therapies to protect blood vessels as people age.
The authors propose that future treatments could involve delivering Nup93 directly to damaged blood vessels to restore their health and prevent cardiovascular diseases. They emphasize the importance of further research to uncover why Nup93 levels decrease with age and how restoring it might improve blood vessel function.
“These latest discoveries provide a fresh and innovative perspective of EC biology, highlighting NPCs as major regulators of EC health that may underlie mechanisms of vascular aging and disease progression.”
In conclusion, the editorial encourages scientists to focus on understanding how endothelial cells stay strong and the role of NPCs in keeping blood vessels healthy. This research could lead to important breakthroughs in slowing down aging and improving people's quality of life.
Read the full paper: DOI: https://doi.org/10.18632/aging.206097
Corresponding author: Monica Y. Lee - monicaYL@uic.edu
Video short: https://www.youtube.com/watch?v=as6opv9_FYM
Keywords: aging, endothelial, vascular, nucleoporin, inflammation
Click here to sign up for free Altmetric alerts about this article.
About Aging:
The journal Aging aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.)
Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
Please visit our website at www.Aging-US.com and connect with us:
Facebook
X
Instagram
YouTube
LinkedIn
Reddit
Pinterest
Spotify, and available wherever you listen to podcasts
Click here to subscribe to Aging publication updates.
For media inquiries, please contact media@impactjournals.com.
Aging (Aging-US) Journal Office
6666 E. Quaker St., Suite 1
Orchard Park, NY 14127
Phone: 1-800-922-0957, option 1
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-11-26
WASHINGTON, Nov. 26, 2024 – Human activities are causing atmospheric carbon dioxide (CO2) levels to rise, which increases the global average surface temperature—and poses a threat to crop growth. Escalating concerns about climate change’s impact on global food security inspired researchers from Banaras Hindu University in India to create a way to explore how these factors influence crop yields.
In Chaos, from AIP Publishing, the researchers share a mathematical model created to capture the nonlinear relationships between CO2, temperature, human population, ...
2024-11-26
About The Study: This cohort study among individuals participating in a weight loss program found that nearly half of those consuming alcohol at baseline decreased their alcohol use after anti-obesity medication initiation. There may be properties of anti-obesity medications that lead to reduced use. For example, naltrexone decreases cravings for alcohol and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may attenuate the rewarding effects of alcohol, similar to food.
Corresponding Author: To contact the corresponding author, Lisa R. Miller-Matero, PhD, email lmatero1@hfhs.org.
To access the embargoed study: Visit our For The Media website at ...
2024-11-26
A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint inhibitors experience increased susceptibility to common infections.
The findings, published in the journal Immunity, provide new insights into immune responses and reveal a potential approach to preventing the common cancer therapy side effect.
“Immune checkpoint inhibitor therapies have revolutionised cancer treatment ...
2024-11-26
Amphibians hold a significant place in evolution, representing the transition from aquatic to terrestrial lifestyles. They are crucial for understanding the brain and spinal cord of tetrapods—animals with four limbs, including humans. A group of scientists led by a team at the Institute of Science and Technology Austria (ISTA) now shows how harmless viruses can be used to illuminate the development of the frog nervous system. The results have now been published in Developmental Cell.
Virus. When you hear the word, you probably shudder. But not all viruses are bad or cause disease. Some are even used for therapeutic ...
2024-11-26
The National Center for Supercomputing Applications and VAST Data are giving supercomputing system Delta and the newly launched DeltaAI a boost in their storage and application performance.
NCSA launched Harbor, a service that provides very fast storage for global home and software directories across all NCSA open-science resources. Its deployment has led to a 400% increase in application launch performance for the Delta system, among many other gains.
Over the last two years, we’ve seen a significant increase in ...
2024-11-26
Researchers have unveiled a groundbreaking advancement in liver failure care: the CATCH-LIFE-MELD score (Chinese Acute-on-Chronic Liver Failure Consortium (CATCH-LIFE)-MELD score). This innovative tool, developed by an international team led by Xia Yu and colleagues, enhances the accuracy of predicting short-term survival outcomes for patients suffering from acute-on-chronic liver failure (ACLF). The study, published in eGastroenterology, promises to revolutionize patient management and treatment planning for this life-threatening condition.
“ACLF presents unique challenges due to its rapid progression and high mortality rates,” said Dr. Yu Shi, senior researcher at Zhejiang University ...
2024-11-26
A recent special issue of the journal Atmospheric and Oceanic Science Letters has brought together some of China's top scientists to provide a picture of the latest progress in understanding and controlling air pollution.
Fine particulate matter, referred to as PM2.5, and ground-level ozone (O3) are the main pollutants degrading the air quality of China’s cities and wider urban regions. Both have serious human health effects, such as heart disease, asthma, and lung damage.
The World Health Organization (WHO) provides clear guidelines regarding acceptable concentrations ...
2024-11-26
SAN FRANCISCO—November 26, 2024—Subtle signs of Alzheimer’s disease can emerge decades before a diagnosis—often in the form of irregular behaviors that reflect very early stages of brain dysfunction.
But until now, identifying and measuring these slight behavioral changes in a scientific way hasn’t been feasible, not even when studying Alzheimer’s in mice.
In a study published in Cell Reports, a team of scientists at Gladstone Institutes used a new video-based machine learning tool to pinpoint ...
2024-11-26
UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 gene-editing technology in humans to directly correct the genetic mutation that causes the disease.
The research involves taking the patient’s blood stem cells to correct the mutation and returning those edited cells to the patient through a bone marrow transplant. It’s hoped the corrected blood stem cells will then multiply and create a new blood system, one free of sickle cell.
“This ...
2024-11-26
Gene editing could create hypoallergenic cats, according to a sequence analysis of the protein that triggers allergies to cats. Some 15% of people are allergic to cats, and symptoms can be severe. Martin D. Chapman and colleagues investigated CH1 and CH2, genes that code for the allergen, Fel d 1. Cats produce Fel d 1 in their sebaceous, salivary, perianal, and lachrymal glands. The function of Fel d 1 is unknown but comparisons of Fel d 1 sequences and homologs from 276 domestic or exotic cats—including cougars, cheetahs, lions, tigers, and jaguars, among others—suggests that CH1 and CH2 have been under active selection, and ...
LAST 30 PRESS RELEASES:
[Press-News.org] Nucleoporin93: A silent protector in vascular health
"Research in the last several decades has established endothelial cells (ECs) as a dynamic interface critical for vascular protection”
